Medtronic PLC (MDT) reports robust growth across key segments, raises full-year EPS guidance, and outlines strategic ...

Medtronic (MDT) recently reported its Q1 FY2026 earnings, showing an increase in sales to $8,578 million, while net income ...

Q1 2026 Earnings Call Transcript August 19, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.26, ...

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Medtronic (MDT) stock in focus as the company raises FY2025 earnings outlook amid Q1 outperformance and reduced tariff impact ...

Medtronic (NYSE:MDT) reports Q1 earnings on Aug 19. Can it sustain revenue growth amid EPS concerns? Learn about key trends, ...

The medical device company posted revenue of $8.58 billion in the period, also beating Street forecasts. Eleven analysts surveyed by Zacks expected $8.37 billion. Medtronic expects full-year earnings ...

Medtronic develops and manufactures a wide range of medical devices, including implantable cardiac pacemakers, heart valves, neurostimulation systems, insulin pumps, and surgical robotics platforms.

Medtronic (MDT) delivered earnings and revenue surprises of +2.44% and +2.50%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Medtronic ( ($MDT) ) has released its Q1 earnings. Here is a breakdown of the information Medtronic presented to its investors. Medtronic plc, ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

In the first quarter of fiscal year 2026, Medtronic saw growth in its overall revenue and neuroscience portfolio, according to financial results posted Aug. 19. Five things to know: 1. Total revenue ...